Vildagliptin (API – CAS 274901-16-5)

Vildagliptin · CAS 274901-16-5 · Antidiabetic

Overview

Vildagliptin is a widely used active pharmaceutical ingredient (API) in the Antidiabetic therapeutic category. It is supplied as a bulk pharmaceutical-grade material manufactured to meet stringent international quality standards.

Therapeutic Application

Vildagliptin is a DPP-4 inhibitor used as monotherapy or in combination with metformin or other oral antidiabetic agents in the management of type 2 diabetes mellitus.

Specifications

• CAS Number: 274901-16-5
• Appearance: White to off-white crystalline powder
• Typical Assay/Purity: ≥ 99.0%
• Common Pharmacopeial Grades: USP, EP, BP, IP
• Storage: Store in a cool, dry place, away from light
• Shelf Life: Typically 24 months under recommended storage conditions

Regulatory & Compliance

Intravarsity adheres to WHO-GMP manufacturing practices, ensuring that Vildagliptin is produced in compliance with international quality standards. Availability of regulatory documents such as USDMF, CEP, and EU-GMP certificates, along with Certificates of Analysis (COA) and Certificates of Suitability (COS), is subject to inquiry.

Packaging & Shipping

Vildagliptin is packaged in 25kg HDPE drums with double LDPE liners, palletized for secure transport. All necessary export documentation is provided, facilitating shipping to key markets including EU, Middle East, SE Asia.

Common Use Cases & Finished Dosage Forms

This API is typically incorporated into various dosage forms including:

• Tablets
• Capsules
• Injectable solutions

Ordering Information

The minimum order quantity (MOQ) for Vildagliptin is subject to inquiry. Interested parties are encouraged to request a Certificate of Analysis (COA) and a quote via this listing. For further inquiries, please contact Intravarsity directly.